Takeda deal looks to bolster biologics pipeline
Takeda partners with Twist Bioscience for access to platform to discover, validate and optimize antibodies in its pipeline.
Takeda partners with Twist Bioscience for access to platform to discover, validate and optimize antibodies in its pipeline.
Blackstone Life Sciences completes first private fund to invest in treatments in late-stage development.
The two partners will use Dewpoint’s platform, focusing on biomolecular condensates, to treat the disease.